Wall Street Analysts See a 33.91% Upside in Collegium Pharmaceutical (COLL): Can the Stock Really Move This High?

Group 1 - Collegium Pharmaceutical (COLL) closed at $32.11, with a 7.4% gain over the past four weeks, and a mean price target of $43 indicates a 33.9% upside potential [1] - The average price targets range from a low of $37.00 to a high of $50.00, with a standard deviation of $5.1, suggesting a variability in estimates; the lowest estimate indicates a 15.2% increase, while the highest points to a 55.7% upside [2] - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price movements, as indicated by a 0.5% increase in the Zacks Consensus Estimate for the current year [4][11][12] Group 2 - COLL has a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential upside [13] - The consensus price target, while not entirely reliable, suggests a positive direction for price movement, which can guide further research into fundamental driving forces [14]